Alpine Global Management, LLC Bausch Health Companies Inc. Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $455,578 - $777,470	74,685 New	74,685 $520,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $706,000 - $2.36 Million	-100,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $540,000 - $694,750	25,000 Added 33.33%	100,000 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $1.73 Million - $2.18 Million	75,000 New	75,000 $2.07 Million
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $4.59 Million - $6.34 Million	-300,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$14.88 - $20.13 $4.46 Million - $6.04 Million	300,000 New	300,000 $4.66 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.